Literature DB >> 17555742

Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain.

Josée Guindon1, Julie Desroches, Mélina Dani, Pierre Beaulieu.   

Abstract

The antinociceptive effects of WIN55,212-2, a synthetic cannabinoid, were evaluated in the model of partial sciatic nerve ligation after daily subcutaneous administration of 0.1 mg/kg a week before and two weeks after surgery. Mechanical allodynia and thermal hyperalgesia were evaluated in 46 rats allocated to receive: (1) Vehicle (before surgery)-Vehicle (after surgery); (2) Vehicle-WIN55,212-2; (3) WIN55,212-2-Vehicle; (4) WIN55,212-2-WIN55,212-2; (5) AM251+vehicle; (6) AM251+WIN55,212-2; (7) AM630+vehicle; (8) AM630+WIN55,212-2; (9) Sham receiving vehicle; and (10) Sham receiving WIN55,212-2. The decreased in mechanical allodynia and thermal hyperalgesia by WIN55,212-2 was significantly greater when it was administered during one week before surgery. In conclusion, pre-emptive use of cannabinoids produced greater antinociceptive effects in a model of neuropathic pain and this effect is mediated by cannabinoid CB(1) and CB(2) receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555742     DOI: 10.1016/j.ejphar.2007.04.060

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.

Authors:  Sudeshna Ghosh; Laura E Wise; Yugang Chen; Ramesh Gujjar; Anu Mahadevan; Benjamin F Cravatt; Aron H Lichtman
Journal:  Life Sci       Date:  2012-06-28       Impact factor: 5.037

Review 2.  Interaction of Cannabis Use and Aging: From Molecule to Mind.

Authors:  Hye Bin Yoo; Jennifer DiMuzio; Francesca M Filbey
Journal:  J Dual Diagn       Date:  2019-09-30

Review 3.  Analgesia for Sheep in Commercial Production: Where to Next?

Authors:  Alison Small; Andrew David Fisher; Caroline Lee; Ian Colditz
Journal:  Animals (Basel)       Date:  2021-04-14       Impact factor: 2.752

4.  Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.

Authors:  Josée Guindon; Ana Guijarro; Daniele Piomelli; Andrea G Hohmann
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 5.  Role of cannabinoids in the treatment of pain and (painful) spasticity.

Authors:  Matthias Karst; Sonja Wippermann; Jörg Ahrens
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

Review 6.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

Review 7.  The analgesic potential of cannabinoids.

Authors:  Jaseena Elikkottil; Jaseena Elikottil; Pankaj Gupta; Kalpna Gupta
Journal:  J Opioid Manag       Date:  2009 Nov-Dec

Review 8.  Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.

Authors:  Elizabeth J Rahn; Andrea G Hohmann
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.

Authors:  Sylvina M Raver; Asaf Keller
Journal:  Neuropharmacology       Date:  2014-07-15       Impact factor: 5.250

10.  Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.

Authors:  Josée Guindon; Yvonne Lai; Sara M Takacs; Heather B Bradshaw; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2012-11-02       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.